Lance Miller to Trypsin Inhibitor, Kazal Pancreatic
This is a "connection" page, showing publications Lance Miller has written about Trypsin Inhibitor, Kazal Pancreatic.
Connection Strength
0.025
-
Soon WW, Miller LD, Black MA, Dalmasso C, Chan XB, Pang B, Ong CW, Salto-Tellez M, Desai KV, Liu ET. Combined genomic and phenotype screening reveals secretory factor SPINK1 as an invasion and survival factor associated with patient prognosis in breast cancer. EMBO Mol Med. 2011 Aug; 3(8):451-64.
Score: 0.025